|
Genfit S.A. (GNFT) DCF Valoración
FR | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Genfit S.A. (GNFT) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de GenFit S.A. (GNFT)! Utilice datos financieros reales de GenFit, ajuste las predicciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de GenFit S.A. (GNFT).
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 32.1 | .8 | 83.3 | 21.0 | 29.7 | 27.4 | 25.3 | 23.4 | 21.6 | 19.9 |
Revenue Growth, % | 0 | -97.52 | 10366.54 | -74.78 | 41.45 | -7.71 | -7.71 | -7.71 | -7.71 | -7.71 |
EBITDA | -53.1 | -94.8 | 36.3 | -24.6 | -23.1 | -18.3 | -16.9 | -15.6 | -14.4 | -13.3 |
EBITDA, % | -165.44 | -11913.07 | 43.59 | -116.88 | -77.84 | -66.85 | -66.85 | -66.85 | -66.85 | -66.85 |
Depreciation | 5.5 | 4.9 | 2.9 | 1.9 | 1.7 | 7.4 | 6.9 | 6.3 | 5.8 | 5.4 |
Depreciation, % | 17.03 | 620.39 | 3.42 | 9.07 | 5.79 | 27.06 | 27.06 | 27.06 | 27.06 | 27.06 |
EBIT | -58.6 | -99.8 | 33.5 | -26.5 | -24.9 | -18.8 | -17.4 | -16.1 | -14.8 | -13.7 |
EBIT, % | -182.47 | -12533.46 | 40.17 | -125.95 | -83.63 | -68.69 | -68.69 | -68.69 | -68.69 | -68.69 |
Total Cash | 288.0 | 178.0 | 269.3 | 146.3 | 81.0 | 27.4 | 25.3 | 23.4 | 21.6 | 19.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 12.5 | 12.4 | 7.5 | 16.6 | 19.3 | 16.0 | 14.8 | 13.6 | 12.6 | 11.6 |
Account Receivables, % | 39.02 | 1558.04 | 9.04 | 78.76 | 64.88 | 58.34 | 58.34 | 58.34 | 58.34 | 58.34 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 0.01297059 | 0.52288 | 0.00499569 | 0.01980688 | 0.01400315 | 0.11493 | 0.11493 | 0.11493 | 0.11493 | 0.11493 |
Accounts Payable | 34.1 | 21.2 | 12.8 | 9.0 | 10.9 | 16.2 | 14.9 | 13.8 | 12.7 | 11.7 |
Accounts Payable, % | 106.21 | 2658.43 | 15.37 | 42.65 | 36.58 | 58.92 | 58.92 | 58.92 | 58.92 | 58.92 |
Capital Expenditure | -2.1 | -.9 | -.6 | .0 | -2.6 | -6.4 | -5.9 | -5.4 | -5.0 | -4.6 |
Capital Expenditure, % | -6.58 | -117.65 | -0.67067 | 0 | -8.71 | -23.19 | -23.19 | -23.19 | -23.19 | -23.19 |
Tax Rate, % | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 |
EBITAT | -58.1 | -99.4 | 32.4 | -26.3 | -25.2 | -18.7 | -17.2 | -15.9 | -14.7 | -13.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -33.1 | -108.2 | 31.2 | -37.3 | -26.9 | -9.1 | -16.2 | -15.0 | -13.8 | -12.8 |
WACC, % | 8.83 | 8.84 | 8.79 | 8.84 | 8.85 | 8.83 | 8.83 | 8.83 | 8.83 | 8.83 |
PV UFCF | ||||||||||
SUM PV UFCF | -51.9 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -13 | |||||||||
Terminal Value | -191 | |||||||||
Present Terminal Value | -125 | |||||||||
Enterprise Value | -177 | |||||||||
Net Debt | -8 | |||||||||
Equity Value | -169 | |||||||||
Diluted Shares Outstanding, MM | 50 | |||||||||
Equity Value Per Share | -3.40 |
What You Will Get
- Real GNFT Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Genfit's future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Genfit Financials: Gain access to precise pre-loaded historical data and future forecasts for Genfit S.A. (GNFT).
- Flexible Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation outcomes.
- Suitable for All Levels: A straightforward, intuitive layout designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file for Genfit S.A. (GNFT).
- Step 2: Review Genfit's pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Genfit S.A. (GNFT)?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Genfit S.A. (GNFT).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Genfit S.A. (GNFT)'s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide a solid foundation for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Genfit S.A. (GNFT).
Who Should Use This Product?
- Investors: Evaluate Genfit S.A.’s (GNFT) market position before making investment decisions.
- CFOs and Financial Analysts: Simplify valuation assessments and validate financial forecasts.
- Startup Founders: Gain insights into how biotech firms like Genfit S.A. (GNFT) are appraised.
- Consultants: Provide detailed valuation reports tailored for clients in the biotech sector.
- Students and Educators: Utilize current data to learn and teach valuation methodologies in finance.
What the Genfit S.A. Template Contains
- Preloaded GNFT Data: Historical and projected financial data, including revenue, EBIT, and research and development expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.